Regeneron Pharmaceuticals
REGN
REGN
541 hedge funds and large institutions have $25.3B invested in Regeneron Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 222 increasing their positions, 185 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 549 → 541 (-8)
11% less call options, than puts
Call options by funds: $630M | Put options by funds: $707M
Holders
541
Holding in Top 10
13
Calls
$630M
Puts
$707M
Top Buyers
1 | +$292M | |
2 | +$278M | |
3 | +$109M | |
4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$81.2M |
5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$79.6M |
Top Sellers
1 | -$2.47B | |
2 | -$770M | |
3 | -$254M | |
4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$229M |
5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$83.9M |